Zevra Therapeutics, Inc. (ZVRA) Net income 2016–2025
Zevra Therapeutics, Inc. (ZVRA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$83.2MFY2025 · since FY2016: -$16.5M → $83.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $83.2M | +178.9% |
| FY2024 | -$105.5M | -129.1% |
| FY2023 | -$46.0M | -72.0% |
| FY2022 | -$26.8M | -212.9% |
| FY2021 | -$8.6M | +33.0% |
| FY2020 | -$12.8M | +48.0% |
| FY2019 | -$24.5M | +56.6% |
| FY2018 | -$56.5M | -30.1% |
| FY2017 | -$43.4M | -162.7% |
| FY2016 | -$16.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZVRA financial trends
ZVRA RevenueZVRA Net marginZVRA Gross profitZVRA Gross marginZVRA Operating incomeZVRA Operating marginZVRA Operating cash flowZVRA Free cash flowZVRA Capital expendituresZVRA Return on equityZVRA Stock buybacksZVRA Dividends paidZVRA Total assetsZVRA Total liabilitiesZVRA Shareholders’ equityZVRA overview →